EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis

Michele Ghidini iD, Fausto Petrelli, Matteo Paccagnella iD, Massimiliano Salati, Francesca Bergamo, Margherita Ratti, Caterina Soldà iD, Barbara Galassi, Ornella Garrone iD, Massimo Rovatti, Arianna Zefelippo iD, Lucio Caccamo iD und 6 weitere

Cancers · 23.07.2025 · 17 (15) · 2445

DOI: 10.3390/cancers17152445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 23.07.2025. Verfasst von Michele Ghidini und 17 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Biliary tract cancers (BTCs) are aggressive malignancies with a poor prognosis. Surgery remains the only curative option, yet recurrence rates are high, and the role of adjuvant chemotherapy remains debated. This study aims to evaluate the impact of adjuvant chemotherapy and prognostic factors on survival outcomes in resected BTCs.

Methods

We conducted a retrospective multicenter study analyzing patients diagnosed with intrahepatic (iCCA) and extrahepatic cholangiocarcinoma (eCCA) or gallbladder cancer (GBC) who underwent curative-intent surgical resection between 1999 and 2023. Demographic, clinicopathological, and treatment data were collected from institutional databases. Survival outcomes were assessed using Kaplan–Meier analysis, and prognostic factors were identified through Cox proportional hazards regression.

Results

A total of 155 patients were included, with a median follow-up of 84.6 months. The cohort comprised 38.7% iCCA, 31.6% eCCA, and 29.7% GBC. R0 resection was achieved in 77.4% of cases, while lymph node involvement was present in 39.4%. Median overall survival (OS) significantly varied by stage (p < 0.001), ranging from >60 months for stage I to ~12 months for stage IVA. Eastern Cooperative Oncology Group (ECOG) performance status (PS) emerged as the strongest independent prognostic factor for OS (p < 0.001). Adjuvant chemotherapy, administered to 49.0% of patients, did not significantly improve OS in the overall cohort (p = 0.899). However, subgroup analyses suggested potential benefits in iCCA and eCCA but not in GBC. High CA19-9 levels and vascular invasion were associated with poorer survival outcomes.

Conclusions

This study highlights the prognostic significance of ECOG PS, resection margin status, lymph node involvement, and CA19-9 levels in resected BTCs. The lack of a clear survival benefit from adjuvant chemotherapy underscores the need for improved therapeutic strategies. Future research should focus on refining risk stratification models and identifying more effective adjuvant treatments to enhance long-term survival outcomes in patients with BTC.

Schlagwörter

Stichwörter der Autor:innen

adjuvant chemotherapybiliary tract cancersextrahepatic cholangiocarcinomagallbladder cancerintrahepatic cholangiocarcinoma

Autor:innen und Institutionen

  • Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Oncology Unit, ASST Bergamo Ovest, 24047 Treviglio, Italy.
  • A.O. Santa Croce e Carle, CTC, 12100 Cuneo, Italy.
  • Department of Oncology and Hematology, University Hospital of Modena, 41124 Modena, Italy.
  • Medical Oncology 1 Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padova, Italy.
  • Oncology Unit, ASST of Cremona, 26100 Cremona, Italy.

ORCID-Profile: Michele Ghidini, Matteo Paccagnella, Caterina Soldà, Ornella Garrone, Arianna Zefelippo, Lucio Caccamo, Enrico Gringeri, Alessandro Zerbi, Guido Torzilli, Silvia Bozzarelli, Lorenza Rimassa, Gianluca Tomasello

Förderung

  • Ministero della Salute
  • Italian Ministry of Health

Zitieren

APA

Ghidini, M., Petrelli, F., Paccagnella, M., Salati, M., Bergamo, F., Ratti, M., Soldà, C., Galassi, B., Garrone, O., Rovatti, M., Zefelippo, A., Caccamo, L., Gringeri, E., Zerbi, A., Torzilli, G., Bozzarelli, S., Rimassa, L., & Tomasello, G. (2025). Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis. Cancers, 17(15), 2445. https://doi.org/10.3390/cancers17152445

Vancouver

Ghidini M, Petrelli F, Paccagnella M, Salati M, Bergamo F, Ratti M, et al. Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis. Cancers. 2025;17(15):2445. doi:10.3390/cancers17152445

BibTeX
@article{Ghidini2025,
  author = {Ghidini, Michele and Petrelli, Fausto and Paccagnella, Matteo and Salati, Massimiliano and Bergamo, Francesca and Ratti, Margherita and Soldà, Caterina and Galassi, Barbara and Garrone, Ornella and Rovatti, Massimo and Zefelippo, Arianna and Caccamo, Lucio and Gringeri, Enrico and Zerbi, Alessandro and Torzilli, Guido and Bozzarelli, Silvia and Rimassa, Lorenza and Tomasello, Gianluca},
  title = {Prognostic Factors and Survival Outcomes in Resected Biliary Tract Cancers: A Multicenter Retrospective Analysis},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {15},
  pages = {2445},
  doi = {10.3390/cancers17152445}
}
Kostenlos starten →